CRA experts advised counsel and presented before the FTC on transactions involving Novartis’ acquisition of cancer drugs from GlaxoSmithKline, GSK’s joint venture with Novartis on consumer health, and Novartis’s sale of Novartis Animal Health to Eli Lilly & Co. The deals ultimately went forward with certain divestitures.
CRA adds Harvard Business School Professor as Academic Affiliate to Antitrust & Competition Economics Practice
“I am pleased to welcome Feng to CRA,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates. “He is a recognized expert on...